[Fungi in feces, fungi in the intestines--therapeutic consequences?].
Yeast in stool specimen are due to transient or commensal growth in the GI tract. Only in immune deficient subjects candida albicans may grow invasively in squamous epithelium. In dermal or vaginal mycosis systemic therapy does not add benefit to local measures. Candida-induced diarrhea in hospitalized patients following chemotherapy stop after a few days of nystatin treatment. Candida hypersensitivity syndrome does not exist, antifungal diet does not eradicate yeast. Stool examination for candida is of no sense because a positive finding is seen in up to 80% of healthy persons.
Rösch
W
W
Medizinischen Klinik am Krankenhaus Nordwest, Frankfurt am Main.
D017088:AIDS-Related Opportunistic Infections / Q000175:diagnosis / Q000188:drug therapy*; D000935:Antifungal Agents / Q000627:therapeutic use; D002176:Candida albicans; D002177:Candidiasis / Q000175:diagnosis* / Q000188:drug therapy; D004064:Digestive System / Q000382:microbiology*; D005243:Feces / Q000382:microbiology*; D005767:Gastrointestinal Diseases / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D016896:Treatment Outcome
D000935:Antifungal Agents
Pilze im Stuhl, Pilze im Darm--therapeutische Konsequenzen?